Predicting disease progression in cystic fibrosis: New use of an old tool

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 1, 2012, Pages 4-5

  Mallory, George B ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IVACAFTOR;

CYSTIC FIBROSIS; DISEASE COURSE; EDITORIAL; EXPIRATORY RESERVE VOLUME; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; LUNG INFECTION; LUNG INSUFFICIENCY; MAXIMAL EXPIRATORY FLOW; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; PREDICTION; PRIORITY JOURNAL; SPIROMETRY; VITAL CAPACITY;

EID: 84863480150     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201205-0822ED     Document Type: Editorial

References (16)

1. Hutchinson J. On the capacity of lungs and on the respiratory function with view of establishing a precise and easy method of detecting diseases by spirometer. Trans Med Soc Lond 1846;29:137-252.
2. Hyatt RE, Schilder DP, Fry DL. Relationship between maximum expiratory flow and degree of lung inflation. J Appl Physiol 1958;13:331-336.
3. Renzetti AD Jr. Standardization in spirometry. Am Rev Respir Dis 1979; 119:831-838.
4. Quanjer PH, ed. Standardized lung function testing. Report working party standardization of lung function tests. European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983;19:1-95.
5. PubMed [accessed 2012 Apr 20]. Available from: PubMed.gov
6. Vilozni D, Lavie M, Sarouk I, Efrati O. Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation? Am J Respir Crit Care Med 2012;186:82-87.
7. Green M, Mead J, Turner JM. Variability of maximum expiratory flow-volume curves. J Appl Physiol 1974;37:67-74.
8. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl JMed 1992;326:1187-1191.
9. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327:1785-1788.
10. Augarten A, Akons H, Aviram M, Bentur L, Blau H, Picard E, Rivlin J, Miller MS, Katznelson D, Szeinberg A, et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant 2001;5:339-342. (Pubitemid 32834800)
11. Rosenbluth D, Wilson K, Ferkol T, Schuster DP. Lung function decline in cystic fibrosis patients and timing for lung transplant referral. Chest 2004;126:412-419. (Pubitemid 39093425)
12. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001;163:1331-1337. (Pubitemid 32506595)
13. Schechter MS, Margolis P. Improving subspecialty healthcare: lessons from cystic fibrosis. J Pediatr 2005;147:295-301. (Pubitemid 41345756)
14. Sanders DB, Li Z, Brody AS, Farrell PM. Chest computerized tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med 2011;184:816-821.
15. Kirby M, Svenningsen S, Ahmed H, Wheatley A, Etemad-Rezai R, Paterson NA, Parraga G. Quantitative evaluation of hyperpolarized helium-3 magnetic resonance imaging of lung function variability in cystic fibrosis. Acad Radiol 2011;18:1006-1013.
16. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 annual data report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011. 12.4.